Sphygmomanometer Market

By Product Type;

Mercury Sphygmomanometer, Aneroid Sphygmomanometer, and Digital Sphygmomanometer

By Operation;

Manual, Electric, Automatic, and Semi-Automatic

By Configuration;

Portable, Desk Mounted, Floor Standing, and Wall Mounted

By End User;

Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centres, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn859518777 Published Date: August, 2025

Sphygmomanometer Market Overview

Sphygmomanometer Market (USD Million)

Sphygmomanometer Market was valued at USD 1,852.09 million in the year 2024. The size of this market is expected to increase to USD 3,609.19 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.0%.


Sphygmomanometer Market

*Market size in USD million

CAGR 10.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)10.0 %
Market Size (2024)USD 1,852.09 Million
Market Size (2031)USD 3,609.19 Million
Market ConcentrationMedium
Report Pages392
1,852.09
2024
3,609.19
2031

Major Players

  • Acoma Medical Industry Co., Ltd
  • AmbulanceMed
  • American DiagnosticCorporation
  • Amico Group of Companies
  • A&D Company, Limited
  • Bremed Ltd.
  • CIGA Healthcare Ltd.
  • Aktiia
  • Nanowear
  • iProven
  • Biobeat

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Sphygmomanometer Market

Fragmented - Highly competitive market without dominant players


The Sphygmomanometer Market is expanding rapidly as healthcare providers prioritize accurate and efficient blood pressure measurement solutions. Nearly 65% of clinics and hospitals now rely on traditional or digital sphygmomanometer devices to manage hypertension and cardiovascular care. This emphasis on diagnostic precision is fueling innovation and market expansion, supported by collaboration between clinical teams and medical device firms.

Innovation in Digital and Portable Options
About 62% of manufacturers are advancing device features such as Bluetooth connectivity, compact portable formats, composite cuff technology, and intuitive digital displays. These enhancements reflect important technological advancements in usability, patient comfort, and monitoring accuracy. Partnerships between technology developers and health providers are accelerating deployment of next-generation instruments.

Collaboration Boosting Clinical Deployment
Collaborative programs involving healthcare centers, diagnostic labs, and device suppliers have driven a 59% increase in usage of modern sphygmomanometers across outpatient, inpatient, and home care settings. These cross-functional collaborations enable consistent training, streamlined protocols, and improved measurement reliability—supporting growth through clinical integration and system alignment.

AI-Enhanced Insights and Next-Gen Monitoring Solutions
Looking ahead, nearly 70% of upcoming sphygmomanometer offerings are expected to incorporate AI-driven analytics, predictive blood pressure trend detection, and integration with remote patient monitoring platforms. The future outlook reflects a shift toward smart, connected healthcare frameworks, empowering clinicians and patients with proactive hypertension management tools.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Operation
    3. Market Snapshot, By Configuration
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Sphygmomanometer Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. More hypertension cases
        2. Higher awareness about checking blood pressure
        3. Better technology for accurate monitoring
        4. Elderly population prone to heart issues
      2. Restraints
        1. Limited clinic availability in some areas
        2. Difficulty ensuring accuracy for all users
        3. Strict monitor sales regulations
      3. Opportunities
        1. Creating user-friendly home monitors
        2. Partnering with apps for remote monitoring
        3. Integrating smart tech for early detection
        4. Using video calls for remote checks
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Sphygmomanometer Market, By Product Type, 2021 - 2031 (USD Million)
      1. Mercury Sphygmomanometer
      2. Aneroid Sphygmomanometer
      3. Digital Sphygmomanometer
    2. Sphygmomanometer Market, By Operation, 2021 - 2031 (USD Million)
      1. Manual
      2. Electric
      3. Automatic
      4. Semi-automatic
    3. Sphygmomanometer Market, By Configuration, 2021 - 2031 (USD Million)
      1. Portable
      2. Desk Mounted
      3. Floor Standing
      4. Wall Mounted
    4. Sphygmomanometer Market, By End Use, 2021 - 2031 (USD Million)
      1. Hospitals &Clinics
      2. Homecare Settings
      3. Ambulatory Surgical Centres
      4. Others
    5. Sphygmomanometer Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Acoma Medical Industry Co., Ltd
      2. AmbulanceMed
      3. American DiagnosticCorporation
      4. Amico Group of Companies
      5. A&D Company, Limited
      6. Bremed Ltd.
      7. CIGA Healthcare Ltd.
      8. Aktiia
      9. Nanowear
      10. iProven
      11. Biobeat
  7. Analyst Views
  8. Future Outlook of the Market